Alaska Invasive Bacterial Disease Surveillance Report Group B Streptococcus – 2015
AIP has conducted statewide surveillance of invasive group B Streptococcus (GBS) since 2000. Beginning in January 2007, invasive GBS became a reportable condition to the State of Alaska Division of Public Health (DPH). Reports of cases of disease caused by this organism are shared between AIP and DPH.
The population of the State of Alaska in 2015 was 737,625; 144,274 (19%) were Alaska Native people. Source: AK Dept. of Labor & Workforce Development population estimates.
An isolate of GBS from a normally sterile site that has been taken from a resident of Alaska. Cases are also included when GBS has been isolated from a placenta and/or amniotic fluid with fetal demise. Early-onset cases are in infants <7 days of age and late-onset are in infants 7-89 days of age.
Participating laboratories send isolates recovered from sterile sites to the AIP laboratory in Anchorage; materials and forms for isolate shipment and data collection are provided to each laboratory by AIP. Demographic and clinical information on the cases are collected from a review of medical records. Annually, AIP asks that each laboratory review their records and provide information on any cases that may have been overlooked.
|No. Cases||Rate*||No. Cases||Rate*|
*Cases per 1,000 live births
|Race||Cases n (%)||Age Adjusted Rate*||% Male||Deaths n (%)|
|Alaska Native||15 (25)||11.1||73%||0 (0)|
|Non-Native†||44 (75)†||6.5||57%||4 (9.1)|
*Cases per 100,000 per percent distribution of Alaska 2010 population
†Includes 7 cases for which race was unknown
|Age (years)||No. Cases||Rate*||No. Cases||Rate*|
*Cases per 100,000 population
|Pneumonia with bacteremia||4||7|
*Percent of cases